The RAG 2 Mouse Model for Xenografted Human Oral Squamous Cell Carcinoma

Contemporary Topics in Laboratory Animal Science

Volumn 41, Issue 2, 2002, Pages 31-35

  Reuther, Tobias ^a,b   Kubler, Alexander C ^a   Staff, Christian J ^a   Flechtenmacher, Christa ^a   Haase, Thomas ^c   Zillmann, Uwe ^d  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c Dept Radiodiagnost Radiotheraphy ^*  (Germany)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ARTICLE; CELL CULTURE; CELL SURVIVAL; COMPARATIVE STUDY; DRUG SCREENING; FEMALE; GRAFT SURVIVAL; HUMAN; IMMUNE DEFICIENCY; IMMUNOLOGY; LYMPH NODE METASTASIS; METASTASIS; METHODOLOGY; MOUSE; MOUSE MUTANT; MOUTH TUMOR; NUDE MOUSE; PATHOLOGY; SPECIES DIFFERENCE; SQUAMOUS CELL CARCINOMA;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL SURVIVAL; FEMALE; GRAFT SURVIVAL; HUMANS; IMMUNOCOMPROMISED HOST; LYMPHATIC METASTASIS; MICE; MICE, NUDE; MICE, SCID; MOUTH NEOPLASMS; SPECIES SPECIFICITY; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0036513113     PISSN: 10600558     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Eveson, J. W. 1981. Animal models of intra-oral chemical carcinogenesis: a review. J. Oral. Pathol. 10:129-146.
2. Gimenez-Conti, I. B., and T. J. Slaga. 1992. The hamster cheek pouch model of carcinogenesis and chemoprevention, p. 63-67. In G. R. Mewell and W. K. Hong (ed.), The biology and prevention of aerodigestive tract cancer. Plenum Press, New York.
3. Salley, J. J. 1954. Experimental carcinogenesis in the cheek pouch of Syrian hamster. J. Dent. Res. 33:253-262.
4. Wong, N. C., and D. F. Wilson. 1983. 4 Nitroquinoline 1-oxide-induced carcinogenesis in the rat palate. J. Oral Pathol. 12:375-384.
5. Lim, H. J., D. Masin, N. L. McIntosh, T. D. Madden, and M.-B. Bally. 2000. Role of drug release and liposome-mediated drug delivery in governing the therapeutic activity of liposomal mitoxantrone used to treat human A431 and LS180 solid tumors. J. Pharmacol. Exp. Ther. 292:337-345.
6. Atillasoy, E. S., R. Elenitsas, E. R. Sauter, P. W. Soballe, and M. Herlyn. 1997. UVB induction of epithelial tumors in human skin using a RAG-1 mouse xenograft model. J. Invest. Dermatol. 109:704-709.
7. Bosma, M. J., and A. M. Carroll. 1991. The SCID mouse mutant: definition, characterization, and potential uses. Ann. Rev. Immunol. 9:323-50.
8. Braakhius, B. J. M., D. A. W. Laarman, J. J. P. Nauta, M. van Walsum, G. A. M. S. van Dongen, and G. B. Snow. 1989. Transplantability of human head and neck squamous cell carcinomas in athymic nude mice. Arch. Otolaryngol. Head Neck Surg. 115:1076-1078.
9. Braakhuis, B. J. M., G. Sneeuwloper, and G. B. Snow. 1984. The potential of the nude mouse xenograft model for the study of head and neck cancer. Arch. Otorhinolaryngol. 239:69-79.
10. Fogh, J., T. J. Orfeo, J. Tiso, F. E. Sharkey, J. M. Fogh, and W. P. Daniels. 1980. Twenty-three new human tumor lines established in nude mice. Exp. Cell Biol. 48:229-239.
11. Giovanella, B. C., J. S. Stehlin, J. Fogh, and F. E. Sharkey. 1978. Serial transplantation of human malignant tumors in nude mice and their use in experimental chemotherapy, p. 163-177. In D. P. Houchens and A. A. Ovejera (ed.), Proceedings of the symposium on the use of athymic (nude) mice in cancer research. Fischer, New York.
12. Moriyama, M. 1999. Development of diffuse invasive (grade 4D) human oral squamous cell carcinoma model in severe combined immunodeficiency mice: microangioarchitectural analysis and im-munohistochemical study. Oral Oncol. 35(4):395-400.
13. Lemon, H. M., B. R. Lutz, R. Pope, L. Parsons, A. H. Handler, and D. I. Patt. 1952. Survival and growth of human tissues transplanted to hamster cheek pouch. Science 115:461-465.
14. Greiner, D. L., D. L. Shultz, J. Yates, et al. 1995. Improved engraftments of human spleen cells in NOD/LtSz-scid/scid mice as compared with C.B.-17-scid/scid mice. Am. J. Path. 146: 888-902
15. Chen, J., R. Lansford, V. Stewart, F. Young, and F. Alt. 1993. RAG 2-deficient blastocyst complementation: an assay of gene function in lymphocyte development. Proc. Natl. Acad. Sci. USA 90(10):4528-4532.
16. Shinkai, Y. L., G. Rathburn, K. P. Lam, E. M. Oltz, V. Stewert, M. Mendelsohn, J. Charron, M. Datta, F. Young, A. M. Stall, and F. W. Alt. 1992. RAG 2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68:855-867.
17. Rehbinder, C., P. Baneux, D. Forbes, H. van Herck, W. Nicklas, Z. Rugaya, and G. Winkler. 1996. FELASA recommendations for the health monitoring of mouse, rat, hamster, gerbil, guinea pig and rabbit experimental units. Lab. Anim. 30:193-208.
18. Dougherty, T. J. 1984. Photodynamic therapy (PDT) of malignant tumors. CRC Crit. Rev. Biochem. 2:83-116.
19. Philpott, K. L., J. L. Viney, G. Kay, S. Rastan, E. M. Gardiner, S. Chae, A. C. Hayday, and M. J. Owen. 1992. Lymphoid development in mice congenitally lacking T cell receptor alpha beta-expressing cells. Science 256(5062):1448-1452.
20. Sauter, E. R., A. J. Klein-Szanto, E. Atillasoy, K. T. Montone, T. Goodrow, R. L. Binder, J. T. Seykora, and M. Herlyn. 1998. Ultraviolet B-induced squamous epithelial and melanocyte cell changes in a xenograft model of cancer development in human skin. Mol. Carcinog. 23:168-174.
21. Rund, L. A., B. K. Cho, T. C. Manning, P. D. Holler, E. J. Roy, and D. M. Kranz. 1999. Bispecific agents target endogenous murine T cells against human tumor xenografts. Int. J. Cancer 83:141-149.
22. Bosma, M. J. 1992. B and T cell leakiness in the scid mouse mutant. Immunodefic. Rev. 3(4):261-76.